154 related articles for article (PubMed ID: 19182823)
21. The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function.
Merchant M; Swart R; Katzman RB; Ikeda M; Ikeda A; Longnecker R; Dykstra ML; Pierce SK
Int Rev Immunol; 2001; 20(6):805-35. PubMed ID: 11913951
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.
Caldwell RG; Wilson JB; Anderson SJ; Longnecker R
Immunity; 1998 Sep; 9(3):405-11. PubMed ID: 9768760
[TBL] [Abstract][Full Text] [Related]
23. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.
Swart R; Ruf IK; Sample J; Longnecker R
J Virol; 2000 Nov; 74(22):10838-45. PubMed ID: 11044134
[TBL] [Abstract][Full Text] [Related]
24. Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A.
Fish K; Comoglio F; Shaffer AL; Ji Y; Pan KT; Scheich S; Oellerich A; Doebele C; Ikeda M; Schaller SJ; Nguyen H; Muppidi J; Wright GW; Urlaub H; Serve H; Staudt LM; Longnecker R; Oellerich T
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26318-26327. PubMed ID: 33020271
[TBL] [Abstract][Full Text] [Related]
25. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
[TBL] [Abstract][Full Text] [Related]
26. A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma.
Bieging KT; Fish K; Bondada S; Longnecker R
Blood; 2011 Dec; 118(26):6849-59. PubMed ID: 22039254
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice.
Caldwell RG; Brown RC; Longnecker R
J Virol; 2000 Feb; 74(3):1101-13. PubMed ID: 10627520
[TBL] [Abstract][Full Text] [Related]
28. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.
Pang MF; Lin KW; Peh SC
Cell Mol Biol Lett; 2009; 14(2):222-47. PubMed ID: 19082921
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.
Anderson LJ; Longnecker R
Blood; 2009 Jan; 113(1):108-16. PubMed ID: 18815281
[TBL] [Abstract][Full Text] [Related]
30. Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.
Rechsteiner MP; Berger C; Weber M; Sigrist JA; Nadal D; Bernasconi M
J Gen Virol; 2007 May; 88(Pt 5):1454-1459. PubMed ID: 17412973
[TBL] [Abstract][Full Text] [Related]
31. Regressing nude mouse grafts of Burkitt's lymphoma x lymphoblastoid cell hybrids show deregulation of the c-myc gene and expression of the EBV latent membrane protein.
Wolf J; Klevenz B; Pawlita M; Komitowski D; Moldenhauer G; zur Hausen H
Int J Cancer; 1991 Jan; 47(1):99-104. PubMed ID: 1702406
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival.
Mancao C; Hammerschmidt W
Blood; 2007 Nov; 110(10):3715-21. PubMed ID: 17682125
[TBL] [Abstract][Full Text] [Related]
33. EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.
Anderson LJ; Longnecker R
J Gen Virol; 2008 Jul; 89(Pt 7):1563-1568. PubMed ID: 18559925
[TBL] [Abstract][Full Text] [Related]
34. Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.
Rechsteiner MP; Berger C; Zauner L; Sigrist JA; Weber M; Longnecker R; Bernasconi M; Nadal D
J Virol; 2008 Feb; 82(4):1739-47. PubMed ID: 18057232
[TBL] [Abstract][Full Text] [Related]
35. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Bauml G; Rucker O; Schwarzmann F; Wolf H; Minarovits J
Med Sci Monit; 2003 Jan; 9(1):HY1-9. PubMed ID: 12552250
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.
Morrison JA; Klingelhutz AJ; Raab-Traub N
J Virol; 2003 Nov; 77(22):12276-84. PubMed ID: 14581564
[TBL] [Abstract][Full Text] [Related]
37. The B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein-Barr virus latent membrane protein 2A.
Ondondo B; Faulkner L; Williams NA; Morgan AJ; Morgan DJ
Cancer Med; 2015 Mar; 4(3):457-71. PubMed ID: 25641882
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development.
Portis T; Longnecker R
J Virol; 2003 Jan; 77(1):105-14. PubMed ID: 12477815
[TBL] [Abstract][Full Text] [Related]
39. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
40. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation.
Konishi K; Maruo S; Kato H; Takada K
J Gen Virol; 2001 Jun; 82(Pt 6):1451-1456. PubMed ID: 11369890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
